Search
KT-333
go.drugbank.com/drugs/DB17165InvestigationalKT-333 is a small molecule targeted protein degrader of STAT3.[L44086]
EI-1071
go.drugbank.com/drugs/DB18486InvestigationalEI-1071 is a selective Colony Stimulating Factor-1 Receptor kinase inhibitor.
Erythropoietin
go.drugbank.com/drugs/DB00016ApprovedInvestigationalIt works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow [FDA Label]. … It has a molecular weight of approximately 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced.
Products: EPORATIO 20000 I E /1ML, EPORATIO 1000 I E /0.5MLViralym-C
go.drugbank.com/drugs/DB17975InvestigationalViralym-C is an investigational T-cell immunotherapy developed by ViraCyte. It consists of Human Leukocyte Antigen (HLA)-matched cytomegalovirus (CMV)-specific T lymphocytes. … It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection.[A260291, L47241]
Allovectin-7
go.drugbank.com/drugs/DB17439InvestigationalIt was discontinued after it failed to improve the objective response rate or overall survival versus first-line chemotherapy in malignant melanoma.[A255207]
Cinalukast
go.drugbank.com/drugs/DB00587ExperimentalUsed in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. … Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
Synonyms: 3'-((E)-2-(4-cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acidPimagedine
go.drugbank.com/drugs/DB05383InvestigationalIt is beneficial in treating patients with diabetic nephropathy. … It is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies.